Skip to main content

FDA ruling on compounding goes Endo's way

The federal agency determined said there is no clinical need to compound vasopressin, a decision that benefits Endo.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.